ADT induces a compensatory activation of MAPK or JNK signaling, combination of JNK inhibitor AS602801 with enzalutamide synergistically inhibits PCa cell proliferation, invasion, and migration in vitro and xenograft tumor development in mouse models [99]. This evidence concerns the gene MAPK8 and posterior cortical atrophy.